These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 3590722

  • 1. [Survival of patients with diffuse glomerulonephritis in disseminated lupus erythematosus treated with a combination of anticoagulants, corticosteroids and immunosuppressants].
    Belovezhdov N, Dimitrova V.
    Vutr Boles; 1987; 26(1):21-7. PubMed ID: 3590722
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of diffuse glomerulonephritis in systemic lupus erythematosus with a combination of anticoagulants, corticosteroids and immunosuppressors].
    Belovezhdov N.
    Vutr Boles; 1985; 24(1):40-9. PubMed ID: 4024608
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of diffuse glomerulonephritis in adults with Schönlein-Henoch disease using a combination of anticoagulants, corticosteroids and immunosuppressants].
    Belovezhdov N.
    Vutr Boles; 1986; 25(2):21-5. PubMed ID: 3716373
    [Abstract] [Full Text] [Related]

  • 4. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R, Palomba D, Satta A, Pirisi M, Tanda F, Bartoli E.
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of diffuse membranous glomerulonephritis with a combination of anticoagulants and corticosteroids].
    Belovezhdov N.
    Vutr Boles; 1984 Dec; 23(5):59-67. PubMed ID: 6523843
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [Abstract] [Full Text] [Related]

  • 7. [Current trends in the treatment of chronic glomerulonephritis].
    Belovezhdov N, Altŭnkova I, Neshev Kh, Robeva R, Gruev I.
    Vutr Boles; 1981 Aug; 20(5):54-64. PubMed ID: 7324454
    [Abstract] [Full Text] [Related]

  • 8. [Intermittent intravenous administration of cyclophosphamide in patients with lupus nephritis].
    Morović-Vergles J, Galesić K, Dancuo I, Vergles D.
    Acta Med Croatica; 2004 Aug; 58(1):13-7. PubMed ID: 15125388
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis.
    Mak SK, Lo KY, Lo MW, Chan SF, Tong GM, Wong PN, Wong AK.
    Nephrology (Carlton); 2008 Jun; 13(4):331-6. PubMed ID: 18476916
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC.
    Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
    [Abstract] [Full Text] [Related]

  • 11. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K, Yu Y, Tang Z, Liu Z, Li L.
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [Abstract] [Full Text] [Related]

  • 12. [Possibilities of combined treatment of diffuse collagenous glomerulonephritis].
    Belovezhdov N, Tsekova D, Dzherasi R, Gruev I, Kiperova B.
    Vutr Boles; 1982 Jul; 21(5):25-34. PubMed ID: 7164403
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K, Tapaneya-Olarn C, Tapaneya-Olarn W.
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [Abstract] [Full Text] [Related]

  • 14. Childhood-onset lupus nephritis: a single-center experience of pulse intravenous cyclophosphamide therapy.
    Barbano G, Gusmano R, Damasio B, Alpigiani MG, Buoncompagni A, Gattorno M, Perfumo F.
    J Nephrol; 2002 Nov; 15(2):123-9. PubMed ID: 12018627
    [Abstract] [Full Text] [Related]

  • 15. [Cyclosporin therapy of patients with systemic lupus erythematosus].
    Gergely P.
    Orv Hetil; 1994 Nov 20; 135(47):2591-5. PubMed ID: 7824258
    [Abstract] [Full Text] [Related]

  • 16. [Therapy of lupus nephritis with standard therapeutic protocols and cyclosporine].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug 20; 130 Suppl 3():13-8. PubMed ID: 12583308
    [Abstract] [Full Text] [Related]

  • 17. Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up.
    Moroni G, Gallelli B, Quaglini S, Banfi G, Rivolta E, Messa P, Ponticelli C.
    Nephrol Dial Transplant; 2006 Jun 20; 21(6):1541-8. PubMed ID: 16455674
    [Abstract] [Full Text] [Related]

  • 18. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Szeto CC, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, Gang W, Li PK.
    Rheumatology (Oxford); 2008 Nov 20; 47(11):1678-81. PubMed ID: 18753192
    [Abstract] [Full Text] [Related]

  • 19. Systemic lupus erythematosus in Thai children: clinicopathologic findings and outcome in 82 patients.
    Pattaragarn A, Sumboonnanonda A, Parichatikanond P, Supavekin S, Suntornpoch V, Vongjirad A.
    J Med Assoc Thai; 2005 Nov 20; 88 Suppl 8():S232-41. PubMed ID: 16856445
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of chronic glomerulonephritis with high doses of intravenous immunoglobulin].
    Belovezhdov N, Monova D, Altŭnkova I, Robeva R.
    Vutr Boles; 1990 Nov 20; 29(1):59-68. PubMed ID: 2396419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.